Silicon Fen is a good place to have a business, Muller tells CNBC
Silicon Valley is not the only place to have tech success, says ARM co-founder Mike Muller in his interview with the news channel CNBC. He explains that UK can compete with the US tech hub from its own Silicon Fen.
Abcodia secures £5.25M for ovarian cancer test
Abcodia today announced that it has raised £5.25million funding from existing and new investors to bring the world's most sensitive and specific ovarian cancer screening test, ROCA® to market. Cambridge Innovation Capital and Scottish Equity Partners co-led the funding round.
Undo 'turns back time' to find bugs that eat 50% of development time
Undo, producers of debugging tools that could save the industry $81bn a year by ‘turning back time’ to find the origins of software problems, has announced it has raised $2m in funding from Cambridge Innovation Capital (CIC), Cambridge Angels, Jaan Tallinn (co-founder of Skype) and Sir Peter Michael (founder of Classic FM), to accelerate its growth.
Genome diagnostic company Congenica raises £2.2m
Cambridge-based Congenica, a spinout from The Wellcome Trust Sanger Institute, has raised a further £2.2m with the completion of a series A round of financing by Amadeus Capital Partners’ early stage funds and the company’s initial investor Cambridge Innovation Capital.
Diagnosis of rare genetic diseases boosted as Congenica gains £2m Genomics England SBRI
Currently many children with rare genetic disorders caused by single gene mutations do not have a specific diagnosis. To help address this issue Congenica – a spinout from the Wellcome Trust Sanger Institute – has been awarded £2m Phase 2 funding by the Small Business Research Initiative (SBRI) announced today by Genomics England.
Definitive diagnosis of rare genetic diseases possible in minutes, says Congenica
Definitive diagnosis of children with rare genetic diseases may soon take minutes rather than years following the announcement that Congenica, the genome discovery and diagnostics company, has gained up to £1M seed funding from Cambridge Innovation Capital to scale up its SapientiaTM analysis platform to support a clinical diagnostic service.
Inivata ‘liquid biopsy’ technology company first lifescience investment for CIC fund
A new technique that allows information about a cancer tumour to be gained quickly from a blood test is a step closer to being used by clinicians. The technology is to be brought to market by Inivata, a new spinout from Cancer Research UK following investment of £4million from Cambridge Innovation Capital, Imperial Innovations and Johnson & Johnson Development Corporation.
CIC announces first three investments from its £50 million Cambridge Cluster Fund
Cambridge Innovation Capital (CIC), an investor in high-growth technology companies in the Cambridge cluster, has completed its first investments from a £50 million fund, backing three companies that address rapidly growing market opportunities in the areas of cloud-based video archiving, grid-scale energy management and generative music composition.
£50 million of long-term capital to support Cambridge technology companies
Intelligent, patient capital to bring innovative technologies to market